PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1+CD38hi cells and anti-PD-1 resistance-Reference-Cited by-同舟云学术

PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1+CD38hi cells and anti-PD-1 resistance

Published:2019-07-29 Issue:9 Volume:20 Page:1231-1243
ISSN:1529-2908
Container-title:Nature Immunology
language:en
Short-container-title:Nat Immunol

Author:

Verma Vivek,Shrimali Rajeev K,Ahmad Shamim,Dai Winjie,Wang Hua,Lu Sumin,Nandre Rahul,Gaur Pankaj,Lopez Jose,Sade-Feldman Moshe,Yizhak Keren,Bjorgaard Stacey L.,Flaherty Keith T.^ORCID,Wargo Jennifer A.^ORCID,Boland Genevieve M.,Sullivan Ryan J.^ORCID,Getz Gad^ORCID,Hammond Scott A.,Tan Ming,Qi Jingjing,Wong Phillip,Merghoub Taha^ORCID,Wolchok Jedd^ORCID,Hacohen Nir^ORCID,Janik John E.,Mkrtichyan Mikayel,Gupta Seema,Khleif Samir N.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy

Link

http://www.nature.com/articles/s41590-019-0441-y.pdf

Reference55 articles.

1. Kyi, C. & Postow, M. A. Checkpoint blocking antibodies in cancer immunotherapy. FEBS Lett. 588, 368–376 (2014).

2. Topalian, S. L., Drake, C. G. & Pardoll, D. M. Immune checkpoint blockade: a common denominator approach to cancer therapy. Cancer Cell 27, 450–461 (2015).

3. Dong, H. et al. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat. Med. 8, 793–800 (2002).

4. Iwai, Y. et al. Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade. Proc. Natl Acad. Sci. USA 99, 12293–12297 (2002).

5. Page, D. B., Postow, M. A., Callahan, M. K., Allison, J. P. & Wolchok, J. D. Immune modulation in cancer with antibodies. Annu. Rev. Med. 65, 185–202 (2014).

Cited by 237 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic vaccine targeting dual immune checkpoints induces potent multifunctional CD8+ T cell anti-tumor immunity;International Immunopharmacology;2024-12

2. Advances in Vaccines for Melanoma;Hematology/Oncology Clinics of North America;2024-10

3. Cell Identity and Spatial Distribution of PD‐1/PD‐L1 Blockade Responders;Advanced Science;2024-09-09

4. CD38 deletion to preserve CAR T cell metabolism and promote functional persistence;Molecular Therapy: Oncology;2024-09

5. High CD38 expression defines a mitochondrial function adapted CD8 + T cell subset with implications for lung cancer immunotherapy;2024-08-28